Antares Pharma reported $18.97M in Cost of Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4933M 54M
Abbvie ABBV:US $ 4142M 121M
Adma Biologics ADMA:US $ 25.44M 2.57M
Aerie Pharmaceuticals AERI:US $ 3.74M 3.04M
Ani Pharmaceuticals ANIP:US $ 35.29M 1.02M
Atrion ATRI:US 22.92M 2.15M
Becton, Dickinson and BDX:US $ 2574M 132M
Cerus CERS:US $ 19.72M 1.64M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Endo International Ordinary Shares ENDP:US $ 179.76M 42.71M
Horizon Pharma HZNP:US $ 230.22M 15.15M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Meridian Bioscience VIVO:US $ 31.04M 11.71M
Orasure Technologies OSUR:US $ 43.44M 7M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Pfizer PFE:US $ 8671M 1339M
Revance Therapeutics RVNC:US $ 7.89M 12K
Sientra SIEN:US $ 8.55M 1.77M
Staar Surgical STAA:US $ 13.94M 0.07M
Supernus Pharmaceuticals SUPN:US $ 20.46M 2.52M
Teva Pharmaceutical TEVA:IT 1.96B 99M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M